EEG abnormalities in clozapine-treated schizophrenic patients (Englisch)
Nationallizenz
- Neue Suche nach: Treves, I.A.
- Neue Suche nach: Neufeld, M.Y.
- Neue Suche nach: Treves, I.A.
- Neue Suche nach: Neufeld, M.Y.
In:
European Neuropsychopharmacology
;
4
, 3
;
393-395
;
1994
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:EEG abnormalities in clozapine-treated schizophrenic patients
-
Beteiligte:Treves, I.A. ( Autor:in ) / Neufeld, M.Y. ( Autor:in )
-
Erschienen in:European Neuropsychopharmacology ; 4, 3 ; 393-395
-
Verlag:
-
Erscheinungsdatum:01.01.1994
-
Format / Umfang:3 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 4, Ausgabe 3
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 165
-
InositolBelmaker, R.H. et al. | 1994
- 167
-
Characterological basis of mixed anxiety and depressionHirschfeld, Robert M.A. et al. | 1994
- 168
-
Outcome of anxiety and depression in general health care: a three-wave 3.5-year study of psychopathology, disability and life stressOrmel, J. / Oldehinkel, T. / Brilman, E. / vanden Brink, W. / Leenstra, A.S. et al. | 1994
- 169
-
Mixed anxiety-depression: prevalence recognition and disability in the WHO-PPGHC studyLecrubier, Yves et al. | 1994
- 170
-
Pharmacological treatment of mixed anxiety and depressionKasper, S. et al. | 1994
- 172
-
Glutamatergic modulation of dopamine functionsÖgren, S.O. et al. | 1994
- 173
-
Mode of action of neuroleptic drugs: role of 5-HT2 receptor antagonismSvensson, Torgny H. et al. | 1994
- 174
-
The enigma of sigma receptorsLeonard, B.E. et al. | 1994
- 176
-
Interactions between gamma-type endorphins and brain dopamine systemsWolterink, G. / Van Ree, J. M. et al. | 1994
- 176
-
Interactions between γ-type endorphins and brain dopamine systemsWolterink, G. / van Ree, J.M. et al. | 1994
- 178
-
Memory systems: current perspectives from psychopharmacologyValerie Curran, H. et al. | 1994
- 179
-
Drugs as tools for investigating memoryDanion, J.M. et al. | 1994
- 181
-
5-HT3 receptor antagonists, cognition and schizophreniaCostall, B. / Naylor, R.J. et al. | 1994
- 182
-
Animal models of memory impairmentCostall, B. / Naylor, R.J. et al. | 1994
- 182
-
Animals models of memory impairmentCostall, B. / Naylor, R. J. et al. | 1994
- 185
-
Is social phobia a relevant illness?Bakish, D. / Hooper, C.L. et al. | 1994
- 186
-
Social phobia in general health careWeiller, E. / Amorin, P. / Boyer, P. / Lépine, J.P. / Lecrubier, Y. et al. | 1994
- 187
-
New approach to treatment of social phobiaBuller, R. et al. | 1994
- 189
-
The molecular cloning of the dopamine receptors and the discovery of the dopamine D4 receptorCivelli, Olivier et al. | 1994
- 190
-
The dopamine D3 receptor in nucleus accumbens: selective cellular localisation, function and regulationSchwartz, J.-C. / Diaz, J. / Griffon, N. / Lammers, C. / Lévesque, D. / Martres, M.P. / Sokoloff, P. et al. | 1994
- 192
-
Structure/function relationship of the dopamine D2 receptorsBorelli, E. / Baik, J.-H. / Picetti, R. / Bhatia, M. et al. | 1994
- 194
-
Dopamine D1 and D5 receptors: molecular cloning and pharmacological characteristicsMonsma, F.J. Jr. / Burgess, L.H. / Sibley, D.R. / Civelli, O. et al. | 1994
- 196
-
Anxiety and aggression as pacemakers of serotonin-related depressionvan Praag, H.M. et al. | 1994
- 197
-
Serotonin mechanisms in schizophreniaMeltzer, H.Y. et al. | 1994
- 198
-
PET studies of 5-HT metabolism in depressionÅgren, H. / Reibring, L. et al. | 1994
- 199
-
Sensation seeking attitudes and risk-taking behaviorsLópez-Ibor, J.J. Jr. / Carrasco, J.L. et al. | 1994
- 200
-
The role of serotonin in the pathophysiology of panic disorderKhan, R.S. et al. | 1994
- 203
-
The epidemiology of dysthymiaAngst, Jules et al. | 1994
- 204
-
Pharmacotherapy for ‘pure’ dysthymia: setraline vs. imipramine and placeboKocsis, J.H. / Thase, M.E. / Koran, L. / Halbreich, U. / Yonkers, K. et al. | 1994
- 204
-
Pharmacotherapy for 'pure' dysthymia: sertraline vs. imipramine and placeboKocsis, J. H. / Thase, M. E. / Koran, L. / Halbreich, U. et al. | 1994
- 205
-
Long-term treatment of depressionKeller, Martin B. et al. | 1994
- 206
-
Globus pallidus and rewardSpyraki, C. et al. | 1994
- 207
-
Behavioral sensitization to drugs of abuseNencini, Paolo / Perrella, Deborah / Paroli, Eugenio et al. | 1994
- 208
-
Endorphins, emotional stress and experimental cocaine addictionvan Ree, Jan M. / Ramsey, Nick F. / Gerrits, Mirjam et al. | 1994
- 211
-
How resistant is resistant depression? Focus on electroconvulsive therapyLerer, B. / Shapira, B. et al. | 1994
- 213
-
Shortened REM latency in severe depression. A correlate of outcomeGrunhaus, L. et al. | 1994
- 214
-
Dopaminergic and serotonergic mechanism in ECSVetulani, J. et al. | 1994
- 216
-
Lithium potentiation and treatment of refractory depressionDinan, T.G. et al. | 1994
- 217
-
Possible neurobiological basis for drug resistance in major depressionde Montigny, C. / Bergeron, R. / Blier, P. et al. | 1994
- 219
-
From ‘real’ pharmacotherapeutic problems in schizophrenia to an ‘ideal’ pharmacodynamic profile for neurolepticsAltamura, A.C. et al. | 1994
- 220
-
The safety of newer and older antipsychoticsKing, D.J. et al. | 1994
- 221
-
D2 and 5-HT2 receptor occupancy in antipsychotic drug treated patientsFarde, L. / Nordström, A. / Nyberg, S. / Halldin, C. et al. | 1994
- 223
-
Movement disorders in schizophrenia and implications for dosage of old and new antipsychoticsBarnes, Thomas R.E. et al. | 1994
- 224
-
Efficacy of olanzapine in the positive and negative symptoms of schizophreniaWood, A.J. / Beasley, C.M. / Tollefson, G.D. / Tran, P.V. et al. | 1994
- 224
-
Efficacy of olanzapine in the positive and negative symptons od schizophreniaWood, A. J. / Beasley, C. M. / Tollefson, G. D. / Tran, P. V. et al. | 1994
- 226
-
The role of nerve growth factor family receptors in the development of the mammalian nervous systemFagan, A.M. / Barbacid, M. / Smeyne, R.J. et al. | 1994
- 226
-
Oxidant stress effects on nigral cell death: Prospects for neuroprotectionYoudim, Moussa B.H. / Riederer, Peter et al. | 1994
- 228
-
The brain kynurenine pathway: relevance in neurological diseaseSchwarcz, R. et al. | 1994
- 229
-
β-Amyloidosis in the pathogenesis of Alzheimer's disease - possible molecular mechanismsHuber, G. / Döbeli, H. / Gschwind, M. / Löffler, J. / Martin, J.R. / Moreau, J.-L. et al. | 1994
- 231
-
Psychopharmacology of suicideTräskman-Bendz, L. / Alsén, M. / Ekedahl, A. / Niméus, A. et al. | 1994
- 232
-
Provocation of aggressive and autoaggressive behavior by psychoactive drugsMöller, H.-J. et al. | 1994
- 234
-
Lithium and treatment of aggressive behaviourTyrer, S.P. et al. | 1994
- 236
-
New biochemical and genetic findings related to aggressionAckenheil, M. / Mueller, N. et al. | 1994
- 236
-
New biochemical and genetic findings related to aggression: a reviewAckenheil, M. / Müller, N. et al. | 1994
- 237
-
Neuroendocrine responses to pharmacological challenge in aggressionCoccaro, E.F. et al. | 1994
- 239
-
Treatment of the cholinergic impairment in Alzheimer's diseaseWilcock, G.K. et al. | 1994
- 240
-
Clinically relevant measures of change in Alzheimer's patientsSchwartz, Gerri E. et al. | 1994
- 241
-
Clinical diagnosis of Alzheimer's disease (AD)Korczyn, Amos D. et al. | 1994
- 241
-
The spectrum of effects of cholinergic treatment of Alzheimer's disease patientsSiegfried, K.R. et al. | 1994
- 243
-
Nimodipine in the treatment of primary degenerative dementiaCutler, N.R. / Morich, F.J. / Gulanski, B. / Sramek, J. et al. | 1994
- 244
-
Autism and the pro-opiomelanocortin systemBuitelaar, J.K. / van Engeland, H. / Kemner, C. / Verbaten, M.N. / Swinkels, S.H.N. et al. | 1994
- 245
-
Neurobiology and drug treatment of Tourette's syndrome and other tic disordersRothenberger, A. et al. | 1994
- 247
-
The psychobiology of obsessive-compulsive disorderWeizman, Abraham et al. | 1994
- 248
-
Recent progress in dopamine transporter researchKuhar, M.J. et al. | 1994
- 249
-
Pharmacology and therapeutic actions of drugs which inhibit neuronal transportersLanger, S.Z. / Agnel, M. / Esnaud, H. / Graham, D. et al. | 1994
- 250
-
Molecular modeling and function of neuronal transportersEdvardsen, Ø. / Dahl, S.G. et al. | 1994
- 252
-
Fear conditioning and extinction: Basic neuronal mechanisms related to PTSDDavis, Michael et al. | 1994
- 252
-
Stress systems in the brain: molecules, nuclei and circuitsWatson, S.J. et al. | 1994
- 254
-
Implications of sensitization and kindling models for the evolution and treatment of post-traumatic stress disorder (PTSD)Post, R.M. / Weiss, S.R.B. / Smith, M.A. et al. | 1994
- 255
-
The neurobiological consequences of early traumatic experiences: focus on corticotropin-releasing factorNemeroff, C.B. / Owens, M.J. / Owens, C.A. / Ehlers, C. / Robbins, T. / Levine, S. et al. | 1994
- 257
-
Abnormal noradrenergic function in panic disorder and PTSDCharney, D.S. et al. | 1994
- 259
-
Dopamine neurotoxic effects on mitochondrial respirationBen-Shachar, D. / Zuk, R. / Klein, E.M. / Galinka, Y. et al. | 1994
- 260
-
Functional expression and properties of NMDA receptor subtypesAvenet, P. / Besnard, F. / Leonardon, J. / Graham, D. / Carter, C. / Nankai, M. / Depoortere, H. / Scatton, B. / Langer, S.Z. et al. | 1994
- 261
-
Modulation of glutamate uptake by oxygen free radicals and changes in the expression of NMDA receptor subunits: relevance to neurotoxicityRacagni, G. / Riva, M. / Trotti, D. / Volterra, A. et al. | 1994
- 262
-
Toxicity of excitatory amino acids and neuroprotection by non-competitive NMDA antagonistsPrivat, A. / Kamenka, J.M. / Drian, M.J. et al. | 1994
- 264
-
Are higher doses more effective in OCD?Fineberg, N.A. / Roberts, A. / Montgomery, S.A. et al. | 1994
- 265
-
OCD and Gilles de la Tourette syndrome — therapeutic issues and implications for mechanismRatzoni, Gidi / Apter, Alan et al. | 1994
- 266
-
Are SSRIs useful in obsessive-compulsive personality disorder?Ansseau, M. et al. | 1994
- 268
-
Experimental models of human anxiety — efficacy of antipanic agentsOlivier, B. / Groenink, L. / Molewijk, H.E. et al. | 1994
- 270
-
New approaches to panic disorderBourin, Michel / Malinge, Myriam / Vasar, E. et al. | 1994
- 273
-
Significance of CCK-B receptors in the neurobiology of panic disorderDen Boer, J.A. / van Megen, H.J.G.M. / Westenberg, H.G.M. et al. | 1994
- 275
-
Differences between panic disorder and generalized anxiety disorder patients in response to alprazolam treatment and withdrawalKlein, E. / Colin, V. / Lenox, R.H. et al. | 1994
- 278
-
Metabotropic glutamate receptors and neuronal apoptosis in cultureNicoletti, F. / Copani, A. / Bruno, V. / Battaglia, G. / Dell'Albani, P. / Condorelli, D.F. et al. | 1994
- 279
-
The pharmacology of excitatory amino acid antagonists in an animal model of strokeGill, R. et al. | 1994
- 282
-
What response is clinically important in negative schizophrenia?Barnes, Thomas R.E. et al. | 1994
- 283
-
Clinically relevant effect sizes in depressionMontgomery, Stuart A. et al. | 1994
- 284
-
Methods of estimating onset of improvementStassen, H.H. / Angst, J. et al. | 1994
- 285
-
Regulatory measures of clinically relevant responsevan Zwieten-Boot, B.J. et al. | 1994
- 287
-
Transcranial magnetic stimulation in depression and schizophreniaGrisaru, N. / Yarovslavsky, U. / Abarbanel, J. / Lamberg, T. / Belmaker, R.H. et al. | 1994
- 288
-
A randomised dosage increase in patients not responding to paroxetine and maprotilineAngersbach, D.H. / Meister, W. / Dunbar, J. / Philipp, M. / Benkert, O. et al. | 1994
- 289
-
Influence of nifedipine on the clinical picture of endogenous affective disordersPanteleyeva, G.P. / Snedkova, L.U. et al. | 1994
- 290
-
Purification and characterization of the serotonin transporter from human brainRotondo, A. / Giannaccini, G. / Betti, L. / Chiellini, G. / Marazziti, D. / Martini, C. / Cassano, G.B. / Lucacchini, A. et al. | 1994
- 290
-
Effects of electroconvulsive treatment on lymphocytes of depressed patientsMarazziti, D. / Raffaelli, S. / Lenzi, A. / Vanacore, R. / Ambrogi, F. / Balestri, C. / Conti, L. et al. | 1994
- 291
-
Utilisation study: fluvoxamine in the treatment of depression in general practiceJaquenoud, E. / Maislisch, L. et al. | 1994
- 292
-
Psychopharmacological effects of low doses of fluoxetine in healthy volunteers: a comparative amphetamine controlled studyWarot, D. / Corruble, E. / Danjou, P. / Lacomblez, L. / Diquet, B. / Puech, A.J. et al. | 1994
- 293
-
Validity of the anticipatory cognitive questionnaire in depression: A multicenter study (preliminary results)López-Ibor, J.J. Jr. / Ayuso-Gutierrez, J.L. / Brieva, J.A.Ramos / Peralta, Y. et al. | 1994
- 294
-
Description and risk factors of the serotonin syndrome in depressed patients treated with tricyclic antidepressantsLejoyeux, M. / Rouillon, F. / Adès, J. et al. | 1994
- 294
-
A comparison of the effects of sertraline and clomipramine on postural blood pressure changes and heart rate and blood pressure variabilityCoupland, N.J. / Wilson, S.J. / Bailey, J.E. / Potokar, J. / Nutt, D.J. et al. | 1994
- 296
-
Initial antidepressant drug treatment effect as a predictor for outcome after 8 weeksVolz, H.-P. / Müller, H. / Sturm, Y. / Möller, H.-J. et al. | 1994
- 297
-
A new method to describe the impact of two antidepressant treatments in daily lifeBarge-Schaapveld, D.Q.C.M. / Nicolson, N.A. / de Vries, M.W. et al. | 1994
- 298
-
Dothiepin tolerability in general practice through two assessment scales of somatizationSchmitt, L. / Boudet, A. / de Sahb, R. / Leutenegger, E. et al. | 1994
- 298
-
Reversal of shuttle-box deficit by 1-phenyl-2-propylaminopentane (PPAP)Gyarmati, S. / Timár, J. / Barna, L. / Knoll, B. / Knoll, J. et al. | 1994
- 299
-
Does concurrent lithium administration potentiate the antidepressant effect of desipramine?Bloch, M. / Schwartzmann, Y. / Bonne, O. / Lerer, B. et al. | 1994
- 300
-
Seizure threshold and the treatment of major depression by electroconvulsive therapyShapira, B. / Gorfine, M. / Lidsky, D. / Lerer, B. et al. | 1994
- 301
-
Response to lithium therapy and the TH geneCauli, G. / Macciardi, F. / Kennedy, J.L. / Verga, M. / Smeraldi, E. et al. | 1994
- 302
-
Haptoglobin levels in a chronic mild stress model of depression in rats before and after treatmentSluzewska, A. / Nowakowska, E. / Gryska, K. / Mackiewicz, A. et al. | 1994
- 303
-
The cognitive and psychomotor effects of acute doses of fluvoxamine and dothiepin in healthy volunteer subjectsSherwood, N. / Hindmarch, I. et al. | 1994
- 303
-
The cognitive and psychomotor effects of acute of fluvoxamine and dothiepin in healthy volunteer subjectsSherwood, N. / Hindmarch, I. et al. | 1994
- 304
-
Plasma levels of the enantiomers of mianserin in CYP2D6-genotyped patientsEap, C.B. / Powell, K. / Taeschner, W. / Baumann, P. et al. | 1994
- 305
-
Treatment of a bipolar psychotic refractory depression with clozapine: a case reportAbbar, M. / Courtet, P. / Caer, Y. / Catelnau, D. et al. | 1994
- 305
-
Treatment of a bipolar psychotic refractory depression with clozapineAbbar, M. / Courtet, P. / Caer, Y. / Catelnau, D. et al. | 1994
- 306
-
Ex vivo monitoring of serotonin transport and serotonin level in rat platelets in the course of treatment with antidepressant drugsJernej, B. / Froebe, A. / Ajhler, T. / Cicin-Sain, L. et al. | 1994
- 306
-
Fluoxetine in the treatment of poststroke depression: a pilot studyStamenkovic, M. / Schindler, S. / Kasper, S. et al. | 1994
- 307
-
Moclobemide and clomipramine in resistant depressions. Six months of combined useSoria, C.A. / Remedi, C. / Flores, M. et al. | 1994
- 308
-
The effect of antidepressant drugs and electroconvulsive shock on the rat hippocampal corticosteroid receptorsPrzegaliński, E. / Budziszewska, B. / Siwanowicz, J. et al. | 1994
- 309
-
Results of a drug monitoring study on moclobemide in general practiceLaux, G. / Baier, D. et al. | 1994
- 309
-
Major depression and SPECT brain imaging with HMPAO-^9^9^mTc: pre and during treatment assessmentsThomas, P. / Vaiva, G. / Maron, M. / Baux, P. et al. | 1994
- 309
-
Major depression and SPECT brain imaging with HMPAO-99mTc: pre and during treatment assessementsThomas, P. / Vaiva, G. / Maron, M. / Baux, P. / Notardonato, L. / Dutoit, D. / Steinling, M. / Goudemand, M. et al. | 1994
- 310
-
The effect of chronic lithium treatment on the caliber of the sural nerve in ratsLicht, R.W. / Smith, D. / Brændgaard, H. et al. | 1994
- 310
-
Psychotropic medication and the suicidal patient: is there a different drug treatment in depressed patients with or without suicidal tendency?Laux, G. / Dapprich, M. et al. | 1994
- 311
-
Regional cerebral blood flow and antidepressant treatment response. Preliminary resultsD'haenen, H. / De Sadeleer, C. / Gelan, P. / Bossuyt, A. et al. | 1994
- 312
-
Differences in regional cerebral blood flow/SPECT scan between major depression and chronic fatigue syndromeFischler, B. / D'haenen, H. / De Metz, K. / Bossuyt, A. et al. | 1994
- 313
-
An investigation of effects of fluvoxamine and dothiepin on sleep and daytime sleepiness in normal volunteersWilson, S.J. / Bailey, J.E. / Ashford, J.J. / Alford, C.J. / Coupland, N.J. / Nutt, D.J. et al. | 1994
- 314
-
Long-term effects of SSRIs and TCAs on sleepWilson, S.J. / Bell, C. / Coupland, N.J. / Nutt, D.J. et al. | 1994
- 315
-
Plasma β-endorphin in depressed patientsEscapat, P. / Pezous, A.M. / Schmitt, A. / Taffani, M. / Moron, P. / Schmitt, L. et al. | 1994
- 316
-
Bipolar affective disorder is not linked to norepinephrine transporter protein or serotonin transporter protein genesGelernter, J. / Kruger, S. / Rao, P. / Amara, S. et al. | 1994
- 317
-
Effects of antidepressants on cyclic AMP responses in the living ratGur, E. / Rogel-Fuchs, Y. / Newman, M.E. / Lerer, B. et al. | 1994
- 317
-
Lithium interferes with coupling of serotonin receptors to their G proteinsWang, H.-Y. / Friedman, E. et al. | 1994
- 318
-
Serotonin stimulation of GTP binding in rat hippocampal membranes and the action of antidepressant drugsSegman, R. / Newman, M.E. / Lerer, B. et al. | 1994
- 319
-
Fluoxetine challenge test and personality dimensions in normal volunteersCabranes, J. A. / Borrego, O. / Ayuso-Gutierrez, J. L. / Baeza, V. et al. | 1994
- 319
-
Fluoxetine challenge test and personality dimesions in normal volunteersCabranes, J.A. / Borrego, O. / Ayuso-Gutiérrez, J.L. / Baeza, V. / Barrabash, A. / Ayuso-Mateos, J.L. et al. | 1994
- 320
-
Effects of 5-HT1A receptor antagonists after acute and chronic citalopram treatment on the activity of 5-HT cells in the dorsal raphe nucleusSvensson, T.H. / Arborelius, L. / Höök, B.Backlund / Hacksell, U. et al. | 1994
- 321
-
The flesinoxan/5-HT1A receptor challenge in major depressionAnsseau, M. / Pitchot, W. / Wauthy, J. / Moreno, A.Gonzalez / Hansenne, M. / Lembreghts, M. / Jammaer, R. / Réel, C. / Gros-Gean, J. / Sulon, J. et al. | 1994
- 321
-
Normalization of the diminished prolactin response to buspirone in major depression during imipramine treatmentLandowski, J. / Sowiński, P. / Wichowicz, H. et al. | 1994
- 322
-
The flesinoxan/5-HT1A receptor challenge and suicidal behaviorAnsseau, M. / Pitchot, W. / Hansenne, M. / Wauthy, J. / Moreno, A.Gonzalez / Jammaer, R. / Réel, C. / Lembreghts, M. / Papart, P. / Gros-Gean, J. et al. | 1994
- 323
-
Contingent negative variation (CNV) in mood disordersPapart, P. / Ansseau, M. / Timsit-Berthier, M. et al. | 1994
- 323
-
Neurochemical and behavioral evidence for a central indirect dopaminergic agonist activity of the antidepressant medifoxamine in miceVaugeois, J.-M. / Pouhé, D. / Lemonnier, F. / Costentin, J. et al. | 1994
- 324
-
A comparison of moclobemide and sertraline in the treatment of depressive disordersDönbak, S. / Türkçapar, H. / Şirin, A. / Akdemir, A. / Demirergi, N. / Öztürk, E. et al. | 1994
- 325
-
Electroconvulsive therapy affects platelet peripheral-type benzodiazepine receptorsWeizman, R. / Karp, L. / Dar, D.E. / Gavish, M. et al. | 1994
- 325
-
A review of methodological approaches for analysing clinical trials on depressed patients: intention to treat and on treatment principlesLehert, Ph. / Galinowsky, A. / Lemonnier, F. et al. | 1994
- 326
-
Effects of several psychotropic drugs on long-lasting rhythmic and emotional effects induced by early atypical Zeitgeber. A possible simulation of depression?Schelstraete, I. / Weyers, M.-H. et al. | 1994
- 327
-
Neuropsychological performances in hyponoradrenergic and hyposerotonergic syndrome in depression: search for predictive profilePaunović, V.R. / Totić, S. / Marinković, D. / Aćimović, B. / Babinski, T. et al. | 1994
- 327
-
Electrophysiological evidence that desmethylsertraline is inactive at blocking central 5-HT uptake in vivoSprouse, J. / Reynolds, L. / Heym, J. et al. | 1994
- 328
-
Spectral analysis of fluctuations in heart rate and blood pressure before and after treatment with imipramine or mirtazapine (ORG.3770) in major depressive disorderTulen, J.H.M. / de Man, K.J. / Bruijn, J.A. / Pepplinkhuizen, L. / van den Meiracker, A.H. / Man in 't Veld, A.J. et al. | 1994
- 329
-
Ultrabrief pulse compared to sine wave ECT: a double-blind prospective randomized controlled studySeifertová, B. / Maršálek, M. / Hyrman, V. / Klashka, J. et al. | 1994
- 330
-
Postnatal depression and peripartum progesterone levels: lack of a direct associationHarris, B. / Lovett, L. / Newcombe, R. / Read, G. et al. | 1994
- 331
-
Pharmacokinetics of fluvoxamine after intravenous and oral administrationvan Harten, J. / Kok, F. / Lönnebo, A. / Grahnén, A. et al. | 1994
- 332
-
A meta-analysis of the efficacy of selective serotonin reuptake inhibitors compared to tricyclic antidepressants in depressionAnderson, I. / Tomenson, B. et al. | 1994
- 332
-
SSRIs in depressed elderly; a double-blind comparison of sertraline and fluoxetine in depressed geriatric outpatientsNewhouse, P.A. / Richter, E.M. et al. | 1994
- 333
-
A double-blind comparison of sertraline and nortriptyline in the treatment of depressed geriatric outpatientsCoffey, D.J. / Richter, E.M. et al. | 1994
- 335
-
The limbic location of some central effects of competitive and noncompetitive NMDA receptor antagonist: The role in emotional controlPlaznik, A. / Nazar, M. / Jessa, M. et al. | 1994
- 336
-
Alexithymia, cerebral lateralization and drug response in patients with panic disorderKalinin, V.V. et al. | 1994
- 336
-
Alexithymia, cerebral lateralizaton and drug response in patients with panic disorderKalinin, V. V. et al. | 1994
- 336
-
Long-term fluvoxamine treatment and platelet-rich plasma serotonin level in symptom-free panic disorder patientsFaludi, G. / Tekes, K. / Borcsiczky, D. / Magyar, I. et al. | 1994
- 337
-
Elevated plus maze activity and serotonergic neurotransmission in Fawn-Hooded ratsBriley, M. / Chopin, P. / Moret, C. et al. | 1994
- 338
-
Modifications of platelet markers during treatment with fluvoxamine of patients with obsessive-compulsive disorderMarazziti, D. / Rotondo, A. / Milanfranchi, A. / Ravagli, S. / Lensi, P. / Palego, L. / Presta, S. / Cassano, G.B. et al. | 1994
- 339
-
A double-blind, placebo-controlled comparison of fluvoxamine, with or without behaviour therapy, in panic disorderSimpson, R.J. / Sharp, D.M. / Holland, R.L. / Kok, G. / Anstee, J.A. et al. | 1994
- 340
-
Single-photon emission computed tomography and obsessive-compulsive disorderMartinez, B. / Höflich, G. / Klemm, E. / Assion, H.-J. / Kasper, S. / Biersack, H.-J. / Möller, H.-J. et al. | 1994
- 341
-
Clomipramine challenge test in obsessive-compulsive disorder: an indicator for altered serotonergic activity/neuroendocrine responsivity?Martinez, B. / Höflich, G. / Rao, M.-L. / Assion, H.-J. / Kasper, S. / Möller, H.-J. et al. | 1994
- 342
-
Comparative study of [3H]serotonin uptake, [3H]imipramine and [3H]paroxetine binding on platelets from drug-free panic disorder patientsMagyar, I. / Tekes, K. / Faludi, G. et al. | 1994
- 343
-
35% CO2 model in panic disorder: a genetic perspectivePerna, G. / Arancio, C. / Bertani, A. / Cocchi, S. / Bellodi, L. et al. | 1994
- 344
-
The effects of drugs acting at the GABA-benzodiazepine-barbiturate receptor complex on the behavior of sleep deprived micePokk, P. / Zharkovsky, A. et al. | 1994
- 344
-
Moclobemide in treating patients with post-traumatic stress disorderFolnegovic-Smalc, V. / Gosev, M. / Mimica, N. / Makaric, G. et al. | 1994
- 344
-
Moclebemide in treating patients with post-traumatic stress disorderFolnegović-Šmalc, V. / Gošev, M. / Mimica, N. / Makarić, G. / Folnegović, Z. et al. | 1994
- 345
-
Effect of diazepam on punished drinking and on plasma corticosterone levels in male and female ratsPeričić, D. / Pivac, N. et al. | 1994
- 346
-
Behavioral effects of non-benzodiazepine anxiolytic drugs - tolerance and memoryNowakowska, E. / Chodera, A. / Słuzewska, A. et al. | 1994
- 347
-
The panic and agoraphobia scale: results of validation processesBandelow, B. / Hajak, G. / Rüther, E. et al. | 1994
- 348
-
Patients prefer drug therapy in panic disorderBandelow, B. / Sievert, K. / Röthemeyer, M. / Hajak, G. / Rüther, E. et al. | 1994
- 349
-
Simulation of panic anxiety in animals with aversive intracerebral stimulation: elements of face and predictive validityJenck, F. / Moreau, J.-L. / Martin, J.R. et al. | 1994
- 350
-
Use of low-dose selective serotonin reuptake inhibitors and cognitive behavioral therapy in agoraphobia with panic attacks: an open studyDutoit, D. / Vaiva, G. / Thomas, P. / Bianchi-Decaix, I. / Goudemand, M. et al. | 1994
- 351
-
Psychophysiological patterns in panic patients before and after amitriptyline treatmentVein, A.M. / Djukova, G.M. / Shepeleva, I.P. et al. | 1994
- 352
-
Brain cholecystokinin levels and receptor binding in anxiety statesHarro, J. / Löfberg, C. / Rehfeld, J. / Oreland, L. et al. | 1994
- 353
-
Norharman and platelet serotonin in panic disorder patients compared with healthy controlsTimmerman, L. / Verhey, R. / Fekkes, D. et al. | 1994
- 353
-
Treatment of school phobia in children and adolescents with fluoxetineDa̧bkowska, M. / Rybakowski, J.K. et al. | 1994
- 354
-
Effect of the cholecystokinin B receptor antagonist L-365-260 on lactate induced panic attacksvan Megen, H.J.G.M. / Westenberg, H.G.M. / den Boer, J.A. et al. | 1994
- 355
-
Anxiolytic activity of single doses of the 5-HT3 antagonist zacoprideAnsseau, M. / Pitchot, W. / Gonzalez Moreno, A. et al. | 1994
- 356
-
Placebo-controlled study of clomipramine in panic patients taking benzodiazepinesAnsseau, M. et al. | 1994
- 356
-
Brofaromine versus fluvoxamine in panic disordervan Vliet, I.M. / den Boer, J.A. / Slaap, B.R. / Westenberg, H.G.M. et al. | 1994
- 357
-
Peripheral-type benzodiazepine receptors in posttraumatic patients following the Gulf warWeizman, R. / Laor, N. / Bidder, M. / Fisher, D. / Fomia, O. / Muller, U. / Reiss, A. / Wolmer, L. / Karp, L. / Gavish, M. et al. | 1994
- 358
-
Fluvoxamine-induced delayed sleep phase syndrome in ten patients with obsessive-compulsive disorderHermesh, H. / Dagan, Y. et al. | 1994
- 359
-
Musical hallucinations as a form of obsessionHermesh, H. / Dar, R. / Lotan, D. / Aizenberg, D. / Avni, A. / Zemishlani, Z. / Munitz, H. et al. | 1994
- 360
-
Differential diagnosis and possible pathogenetic mechanisms of obsessive-compulsive syndromesMüller, N. / Putz, A. / Kathmann, N. / Straube, A. / Ackenheil, M. et al. | 1994
- 361
-
Cerebral glucose metabolic changes after stereotactic leukotomy for refractory obsessive-compulsive disorder: a case reportFrançois, A. / Biver, F. / Goldman, S. / Luxen, A. / Gribomont, B. / Lotstra, F. et al. | 1994
- 361
-
Cerebral glucose metabolic changes after stereotactic leukotomy for refractory obsessive-compulsive disorderFrancois, A. / Biver, F. / Goldman, S. / Luxen, A. et al. | 1994
- 362
-
Patient cognitions as a useful diagnostic indicator in the differentiation of non-ischemic from ischemic chest painFraenkel, Yehudah M. / Kindler, Seth / Melmed, Raphael N. et al. | 1994
- 362
-
[3H]Imipramine in posttraumatic patientsWeizman, R. / Laor, N. / Schujovizky, A. / Wolmer, L. / Abramovitz-Schnaider, P. / Rehavi, M. et al. | 1994
- 364
-
Psychotropic drugs and cerebral asymmetry in psychosisEgorov, A.Y. et al. | 1994
- 365
-
The difference among effects of haloperidol, (−)-sulpiride and SCH23390 on the expression of c-fos and c-jun mRNA inductionsOzaki, T. / Yokotani, N. / Katsumoto, E. / Onishi, H. / Yamagami, S. et al. | 1994
- 366
-
Use of α-tocopherol for correction of movement disorders in long-term neuroleptic treatmentDikaya, V.I. et al. | 1994
- 367
-
Disturbance of serotonergic or glutamatergic neurotransmission results in hyperfrontality as measured by PET and FDG in acute human model psychosesVollenweider, F.X. / Scharfetter, Ch. / Leenders, K.L. / Angst, J. et al. | 1994
- 368
-
Epidemiology and psychiatric background variables of parasuicidal behavior; results of the WHO/EURO multicenter prediction studyHawellek, B. / Laux, G. / Möller, H.-J. et al. | 1994
- 369
-
An open trial with 7-methoxytacrine in tardive dyskinesiaMaršálek, M. / Filip, V. / Prašková, H. / Karen, P. et al. | 1994
- 370
-
Levomepromazine — a substrate of cytochrome CYP2D6?Höflich, G. / Kolbinger, M. / Baumann, P. / Jonzier-Perey, M. / Rao, M.L. / Bagli, M. / Langer, M. / Kasper, S. / Möller, H/-J. et al. | 1994
- 371
-
Inositol trisphosphate and cytosolic calcium level in activated platelets of schizophrenicsŘípová, D. / Němcová, V. / Strunecká, A. / Höschl, C. et al. | 1994
- 372
-
Phosphoinositide signalling system in resting platelets of schizophrenicsŘípová, D. / Némcová, V. / Růžička, P. / Strunecká, A. / Höschl, C. et al. | 1994
- 373
-
ADH, aldosterone, angiotensin, renin, plasma-renin activity and cortisol in untreated schizophrinics with special relation to test therapy and treatment responseVolz, H.-P. / Friedrich, A. / Mackert, A. / Diefenbacher, A. / Möller, H.-J. et al. | 1994
- 373
-
ADH, aldosterone, angiotensin, renin, plasma-renin activity and cortisol in untreated schizophrenics with special relation to test therapy and treatment responseVolz, H. P. / Friedrich, A. / Mackert, A. / Diefenbacher, A. et al. | 1994
- 373
-
Candidate gene study of the catecholamine system in schizophreniaCrowe, R.R. / Wang, Z.W. / Black, D.W. / Andreasen, N.C. / Gelernter, J. / Persico, A.M. et al. | 1994
- 374
-
An overlap between schizophrenia and affective disorders: preliminary results of a family studyKnobler, H.Y. / Hanin, B. / Itzchaky, S. / Maizel, S. / Lerner, Y. et al. | 1994
- 375
-
Vitamin E treatment of persistent tardive dyskinesia: a double-blind, placebo-controlled, cross-over studyCavallaro, R. / Regazzetti, M.G. / Rizzoli, A.A. / Martines, A. / Smeraldi, E. et al. | 1994
- 375
-
Association between schizophrenia and the dopamine receptor DRD4Macciardi, F. / Verga, M. / Kennedy, J.L. / Cavallini, M.C. / Catalano, M. / Smeraldi, E. et al. | 1994
- 376
-
Genetic control of the metabolism of neuroleptics: implications for the management of therapeutic dosages and side effectsMarino, C. / Macciardi, F. / Cavallaro, R. / Cohen, S. / Smeraldi, E. et al. | 1994
- 377
-
Treatment of drug-induced psychosis in Parkinson's disease with clozapineCourtet, P. / Abbar, M. / Caer, Y. / Castelnau, D. et al. | 1994
- 377
-
Treatment of drug-induced psychosis in Parkinson's disease with clozapine: a case reportCourtet, P. / Abbar, M. / Caer, Y. / Castelnau, D. et al. | 1994
- 378
-
GABA and flunitrazepam binding inhibitor levels in native plasma of healthy women, healthy men and male schizophrenic patientsTvrdeić, A. / Peričić, D. et al. | 1994
- 379
-
Genetic linkage and association studies of schizophrenia and related disorders using dopamine transporter gene markersPersico, A.M. / Macciardi, F. / Cavallini, M.C. / Crowe, R.R. / Wang, Z.W. / Uhl, G.R. / Smeraldi, E. et al. | 1994
- 380
-
Impairment of strategies underlying verbal fluency performance in schizophrenia; relationships with prefrontal cortex dysfunctionRobert, Ph. / Migneco, V. / Fusey, S. / Giacomoni, F. / Benoit, M. / Darcourt, G. et al. | 1994
- 381
-
Anti-cardiolipin AB in multicase families with schzophreniaSirota, P. / Schild, K. / Firer, M. / Elizur, A. / Slor, H. et al. | 1994
- 381
-
Regional cerebral blood flow before and after low doses of amisulpride in negative schizophreniaVaiva, G. / Dutoit, D. / Thomas, P. / Cottencin, O. / Steinling, M. / Goudemand, M. et al. | 1994
- 381
-
Anti-cardiolipin AB in multicase families with schizophreniaSirota, P. / Schild, K. / Firer, M. / Elizur, A. et al. | 1994
- 382
-
Towards an understanding of acute oral dyskinesia in sensitized animals. An evaluation of dopaminergic and cholinergic mechanismsLublin, H. / Gerlach, J. et al. | 1994
- 383
-
Fluphenazine and clozapine in chronic psychotic patients: a pilot studyKores, B.P. / Novak, V.G. / Zalar, B. et al. | 1994
- 383
-
Zuclopenthixol co-injection in acute exacerbation of chronic psychosis in Finland and EstoniaVartiainen, H. / Koponen, H. / Vasar, V. / Mehilane, L. et al. | 1994
- 384
-
A multicentre, double-blind, placebo-controlled comparison of low and high dosage regimens of SeroquelTM in the treatment of hospitalised patients with acute exacerbation of subchronic or chronic schizophreniaHirsch, S. / Arvanitis, L. / Miller, B. / Smith, A. et al. | 1994
- 385
-
Serum levels of fluphenazine in schizophrenic outpatients maintained on two reduced doses of fluphenazine decanoateHeresco-Levy, U. / Lerer, B. / Greenberg, D. / Javitt, D.C. / Brown, W.A. et al. | 1994
- 385
-
A multicentre, placebo-controlled, double-blind evaluation of SeroquelTM in hospitalised patients with acute exacerbation of chronic and subchronic schizophreniaArvanitis, L. / Miller, B. / Fennimore, J. et al. | 1994
- 385
-
A multicentre, double-blind, controlled comparison of SeroquelTM and chlorpromazine in the treatment of hospitalised patients with acute exacerbation of subchronic and chronic schizophreniaLink, C. / Smith, A. / Miller, B. / Ryan, J. et al. | 1994
- 386
-
Pharmacological effects of rimcazole and 1,3-di-o-tolylguanidine, sigma receptor ligands, as potential antipsychotic agentsMaj, J. / Rogóż, Z. / Skuza, G. et al. | 1994
- 387
-
Tardive dyskinesia in a Scottish psychiatric hospital populationLivingston, M.G. et al. | 1994
- 387
-
Risperidone in the treatment of therapy-resistant schizophrenia: four case historiesPetersson, E. / Eriksson, L. et al. | 1994
- 388
-
Selective actions of the novel atypical antipsychotic drug amperozide in the limbic forebrainNomikos, G.G. / Marcus, M.M. / Fibiger, H.C. / Svensson, T.H. et al. | 1994
- 389
-
Tiapride with senile psychoses. The effect on negative symptoms of schizophreniaBukatina, E.E. / Grigoriyeva, I.V. / Smirnov, O.R. et al. | 1994
- 390
-
Differential induction of early gene expression in the CNS by antipsychoticsRogue, P. / Vincendon, G. et al. | 1994
- 390
-
Expressed emotion (EE) of families of psychotic inpatients: its effect on outcome and on neuroleptic efficacyMarom, S. / Hermesh, H. / Carmeli, Z. / Avni, A. / Munitz, H. et al. | 1994
- 391
-
Effect of antiparkinson drugs on memory in medicated chronic schizophrenicsSilver, H. et al. | 1994
- 392
-
Duration of untreated psychosis during first year of illness as a predictor of prognosis in schizophreniaRzewuska, M. et al. | 1994
- 392
-
Serotonergic augmentation of typical and atypical antipsychotics in treatment-resitent chronic schizophreniaSilver, H. et al. | 1994
- 392
-
Serotonergic augmentation of typical and atypical antipsychotics in treatment-resistant chronic schizophreniaSilver, H. et al. | 1994
- 392
-
Effect of antiparkinsonian drugs on memory in medicated chronic schizophrenicsSilver, H. et al. | 1994
- 393
-
EEG abnormalities in clozapine-treated schizophrenic patientsTreves, I.A. / Neufeld, M.Y. et al. | 1994
- 396
-
Memory effects of the natural product Mumyo on the water maze in ratsSpassov, V. et al. | 1994
- 397
-
Effects of S-12024 on middle cerebral artery blood flow velocities in Alzheimer's disease: a transcranial doppler studyCaamaño, J. / Gómez, M.J. / Franco, A. / Vinagre, D. / Alvarez, X.A. / Fernández-Novoa, L. / Novo, B. / Zas, R. / García, M. / Gorostiaga, C. et al. | 1994
- 397
-
Behavioral and neuroimmune effects of anapsos in cognitively impaired ratsAlvarez, X.A. / Fernández-Novoa, L. / Zas, R. / Caamaño, J. / Novo, B. / Díaz, J. / Sempere, J.M. / Cacabelos, R. et al. | 1994
- 398
-
S 9977-2 normalizes behavior and brain interleukin-1β levels in rats with lesions in the nucleus basalis of MeynertAlvarez, X.A. / Fernández-Novoa, L. / Zas, R. / Franco, A. / Kamoun, A. / Deslandes, A. / Polo, E. / Gorostiaga, C. / Cacabelos, R. et al. | 1994
- 399
-
Effects of Polypodium leucotomos (difur) on behavioral parameters and brain neuroimmune factors in nbM-lesioned ratsAlvarez, X.A. / Fernández-Novoa, L. / Zas, R. / Vinagre, D. / Gómez, M.J. / Sada, G. / Cacabelos, R. et al. | 1994
- 399
-
The effects of hydergine on the MAO activity of the aged and adult rat brainHariri, N.I. / Büyüköztürk, A. / Kanit, L. / Ersöz, B. / Menteş, G. et al. | 1994
- 400
-
Sources of differentiation of cocaine withdrawal symptomatologyMannelli, P. / Janiri, L. / Mizzoni, M.C. / Tempesta, E. et al. | 1994
- 401
-
Normal tau protein and hyperphosphorylated tau protein in cerebrospinal fluid: a biochemical marker for Alzheimer's disease?Blennow, K. et al. | 1994
- 402
-
Evaluation of lithium treatment in alcoholism: a reviewLejoyeux, M. / Adès, J. / Léon, E. et al. | 1994
- 403
-
Evaluation of lithium treatment in alcoholismLejoyeux, M. / Ades, J. / Leon, E. et al. | 1994
- 403
-
Pharmacological control by piracetam and aniracetam of cognitive deficits in rats with fetal alcohol syndromeVaglenova, J.V. / Petkov, V.V. et al. | 1994
- 404
-
(−)Deprenyl fails to potentiate phenyl-ethyl-amine-induced place preference conditioningTimár, J. / Újvári, M. / Tóth, M. / Gyarmati, Zs. / Knoll, B. et al. | 1994
- 404
-
Dotarizine prevent electroconvulsive shock- and pentylenetetrazol-induced amnesia in ratsLazarova-Bakarova, M.B. / Petkova, B. / Petkov, V.D. et al. | 1994
- 405
-
Dotarizine prevents electroconvulsive shock- and pentylenetetrazol-induced amnesia in ratsLazarova-Bakarova, M. B. / Petkova, B. / Petkov, V. D. et al. | 1994
- 405
-
Piracetam and fipexide abolish the amnesia provoked by PTZ kindling in ratsGenkova-Papazova, M. / Lazarova-Bakarova, M. et al. | 1994
- 406
-
Effect of normal aging on 5-HT1A receptor mediated temperature and hormone responsesGelfin, G. / Lesch, K.P. / Lerer, B. et al. | 1994
- 407
-
Psychological and neurochemical aspects in usual and successful cerebral agingMarchesi, G.F. / Nardi, B. / Pannelli, G. / Mariani, L. / Pierini, C. / Alesiani, M. et al. | 1994
- 408
-
Inpatient opiate detoxification with levomethadone and comedicationKrappel, C. / Laux, G. / Danos, P. / Höflich, G. / Kasper, S. / Möller, H.-J. et al. | 1994
- 409
-
Earlier onset of psychostimulant use and the D2 dopamine receptor gene TaqI A1 RFLP predict preferential psychostimulant use in polysubstance abusersPersico, A.M. / Bird, G. / Gabbay, F.H. / Uhl, G.R. et al. | 1994
- 409
-
Impairment of cognitive function in X-linked adrenoleukodystrophyMaurer, I. / Zierz, S. / Möller, H.-J. et al. | 1994
- 410
-
Effects of S-12024 on brain electrical activity in patients with Alzheimer's diseaseFranco-Maside, A. / Vinagre, D. / Caamaño, J. / Gómez, M.J. / Alvarez, X.A. / Fernández-Novoa, L. / Novo, B. / Zas, R. / Gorostiaga, C. / Polo, E. et al. | 1994
- 411
-
The basic cellular changes in degenerative dementia — neuronal atrophy and loss of synapsesBrun, A. et al. | 1994
- 411
-
Internal consistency of a new scale for the evaluation of benzodiazepine withdrawal syndromeCesana, B.M. / Petracca, A. / Chiroli, S. / Borghi, C. / Cassano, G.B. et al. | 1994
- 412
-
Similar effects of non-competitive and competitive NMDA antagonists in conditioned place preference in ratsPapp, M. / Moryl, E. et al. | 1994
- 413
-
Similar effects of non-competitive and competitive NMDA antagonistsPapp, M. / Moryl, E. et al. | 1994
- 413
-
The NOSGER (nurses' observation scale for geriatric patients): new dara regarding its validity and sensitivity to changeSpiegel, R. / Wahle, M. / Häller, S. et al. | 1994
- 414
-
Analysis of the effects of selegiline (L-deprenyl) on memory in Alzheimer's disease using Sternberg's paradigmFilip, V. / Klaschka, J. et al. | 1994
- 414
-
The NOSGER (nurses' observation scale for geriatric patients): new data regarding its validity and sensitivity to changeSpiegel, R. / Wahle, M. / Haeller, S. et al. | 1994
- 414
-
An evolution study of dementia of the Alzheimer type (DAT) in patients undergoing treatment with citicoline, calcium antagonist and piracetam during one yearLoza, A.Soto / Otazo, A.Ruiz / Merino, C.Medina / de la Torre, A.Alonso / Valverde, J.Franch / Caballero, J.Viaña et al. | 1994
- 415
-
Cerebral asymmetry in emotional control, mechanisms of mood disorders and therapyDeglin, V.L. et al. | 1994
- 416
-
The effect of chronic peripheral inositol administration on Li-pilocarpine seizures and rat brain inositol levelsAgam, G. / Bersudsky, Y. / Kofman, O. et al. | 1994
- 417
-
The effect of inositol on cognitive processes and mood states in normal volunteersLevine, J. / Pomerantz, T. / Belmaker, R.H. et al. | 1994
- 418
-
The involvement of voltage-dependent calcium channel in the mechanism of ECS actionAntkiewicz-Michaluk, L. / Michaluk, J. / Vetulani, J. et al. | 1994
- 419
-
Effects of inositol on lithium-induced EEG abnormalitiesBarak, Y. / Levine, J. / Belmaker, R.H. et al. | 1994
- 419
-
The 4-dedimethylamino derivative of tetracycline loses both ability to block cyclic AMP accumulation and ability to inhibit rat motor activityKofman, O. / Belmaker, R.H. / Mork, A. / Geisler, A. et al. | 1994
- 420
-
Participation of excitatory amino acids transmitter mechanisms in the anticonvulsive activity of barbiturate derivativesGuetova-Spassova, D.P. et al. | 1994
- 422
-
Bromocriptine — further behavioural and biochemical studiesJackson, D.M. / Mohell, N. / Georgiev, J. / Bengtsson, A. / Larsson, L.-G. / Magnusson, O. / Ross, S.B. et al. | 1994
- 422
-
Involvement of cholinergic activity of the caudate-putamen in memory consolidation: a mapping studyQuirarte, G. / Salado-Castillo, R. / Prado-Alcala, R.A. et al. | 1994
- 423
-
I.c.v. inositol does not reverse seizures elicited by the inositol monophosphatase inhibitor R-76COONa and pilocarpineAgam, G. / Kofman, O. / Shapiro, J. et al. | 1994
- 424
-
Nerve growth factor receptor on human platelets: identification and mechanism of platelet activationBrusov, O.S. / Chekalina, N.D. / Klushnik, T.P. et al. | 1994
- 425
-
The 5-HT1A receptor subtype in various regions of the human brainPalego, L. / Marazziti, D. / Mazzanti, C. / Rotondo, A. / Batistini, A. / Martini, C. / Lucacchini, A. / Ladinsky, H. / Cassano, G.B. et al. | 1994
- 426
-
Muscarinic M1 and M2 receptor mechanisms in the regulation of in vivo acetylcholine release in the rat striatumÖgren, S.O. / Pramanik, A. et al. | 1994